Literature DB >> 11555159

Salivary albumin, total protein, IgA, IgG and IgM concentrations and occurrence of some periodontopathogens in HIV-infected patients: a 2-year follow-up study.

L Mellanen1, T Sorsa, J Lähdevirta, M Helenius, K Kari, J H Meurman.   

Abstract

HIV infection reduces oral defensive mechanisms and may affect mucosal integrity. Differences in salivary protein concentrations and periodontopathogenic bacteria were studied in 56 HIV-infected patients with respect to their disease phase. Thirty-three patients were followed up for 2 years. Fifty-three healthy subjects of corresponding age and sex were studied as controls. At baseline, salivary albumin, total protein, IgA, and IgM levels were significantly higher (P<0.05-0.0001) in all phases of HIV infection, except the asymptomatic (ASX) phase, when compared with the control group. IgG levels were significantly increased in all phases except the ASX phase (P<0.05). After 2 years, salivary total protein, IgG, and IgM levels were still higher (P<0.05-0.005) in all HIV phases when compared with the control group (P<0.05-0.005). The albumin level was significantly higher in the ASX phase (P<0.005) and in the AIDS-related complex phase (ARC) (P<0.05), while the increase in IgA level was significant only in the ARC phase (P<0.005). Periodontopathogenic bacteria analyzed by PCR were detected both in the patients and the non-infected, but a statistically significant difference in the carriage percentage between the follow-up lymphadenopathy syndrome phase (LAS) and the control group was found only in Porphyromonas gingivalis (P<0.05) and Bacteroides forsythus (P< 0.0001). Thus, HIV infection appeared to cause a significant increase in the studied salivary proteins, suggesting leakage of serum components into the mouth.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11555159     DOI: 10.1034/j.1600-0714.2001.300908.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  8 in total

1.  Studies of fluorescence immunosensor using eggshell membrane as immobilization matrix.

Authors:  Jieli Tang; Lu Han; Yanhui Yu; Jing Kang; Yihua Zhang
Journal:  J Fluoresc       Date:  2010-10-02       Impact factor: 2.217

2.  Inhibition of human immunodeficiency virus type 1 entry by a binding domain of Porphyromonas gingivalis gingipain.

Authors:  Hua Xie; Natalya I Belogortseva; Jie Wu; Wei-Hong Lai; Chin-ho Chen
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

3.  Salivary constituents and acidogenic microbial counts in coronary artery bypass graft patients from baseline to three-years after operation.

Authors:  Markku Qvarnström; Sok-Ja Janket; Pekka Nuutinen; Jussi Furuholm; Jukka H Meurman
Journal:  Clin Oral Investig       Date:  2007-03-31       Impact factor: 3.573

4.  Saliva in perimenopausal and early postmenopausal women. A 2-year follow-up study.

Authors:  Laura Tarkkila; Jussi Furuholm; Aila Tiitinen; Jukka H Meurman
Journal:  Clin Oral Investig       Date:  2011-06-03       Impact factor: 3.573

5.  Using lysine adducts of human serum albumin to investigate the disposition of exogenous formaldehyde in human blood.

Authors:  Luca G Regazzoni; Hasmik Grigoryan; Zhiying Ji; Xi Chen; Sarah I Daniels; Deyin Huang; Sylvia Sanchez; Naijun Tang; Fenna C M Sillé; Anthony T Iavarone; Evan R Williams; Luoping Zhang; Stephen M Rappaport
Journal:  Toxicol Lett       Date:  2017-01-16       Impact factor: 4.372

6.  Salivary IgA versus HIV and Dental Caries.

Authors:  Pradip Kumar Mandal; Malay Mitra; Sonu Acharya; Chiranjit Ghosh; Susant Mohanty; Subrata Saha
Journal:  J Clin Diagn Res       Date:  2016-09-01

7.  Salivary enzymes and flow rate: Markers of peptic ulcer.

Authors:  Moslem Boghori; Mahmoudreza Aghamaali; Reyhaneh Sariri; Fahime Mohamadpour; Hosein Ghafouri
Journal:  J Oral Biol Craniofac Res       Date:  2014-01-16

8.  Porphyromonas gingivalis-mediated Epithelial Cell Entry of HIV-1.

Authors:  C K Mantri; C Chen; X Dong; J S Goodwin; H Xie
Journal:  J Dent Res       Date:  2014-05-29       Impact factor: 6.116

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.